miRNA-29b Suppresses Prostate Cancer Metastasis by Regulating Epithelial–Mesenchymal Transition Signaling
Open Access
- 1 May 2012
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
- Vol. 11 (5), 1166-1173
- https://doi.org/10.1158/1535-7163.mct-12-0100
Abstract
Prostate cancer remains the second leading cause of cancer deaths among American men. Early diagnosis increases survival rate in patients; however, treatments for advanced disease are limited to hormone ablation techniques and palliative care. Thus, new methods of treatment are necessary for inhibiting prostate cancer disease progression. Here, we have shown that miRNA-29b (miR-29b) expression was lower in prostate cancer cells (PC3 and LNCaP) as compared with immortalized prostate epithelial cells. Between these two prostate cancer cell lines, metastatic prostate cancer PC3 cells displayed lower expression of miR-29b. We also observed a significant downregulation of miR-29b expression in human prostate cancer tissues as compared with patient-matched nontumor tissues. PC3 cells ectopically expressing miR-29b inhibited wound healing, invasiveness, and failed to colonize in the lungs and liver of severe combined immunodeficient mice after intravenous injection, while PC3 cells expressing a control miRNA displayed metastasis. Epithelial cell marker E-cadherin expression was enhanced miR-29b transfected in prostate cancer cells as compared with cells expressing control miRNA. On the other hand, N-cadherin, Twist, and Snail expression was downregulated in PC3 cells expressing miR-29b. Together these results suggested that miR-29b acts as an antimetastatic miRNA for prostate cancer cells at multiple steps in a metastatic cascade. Therefore, miR-29b could be a potentially new attractive target for therapeutic intervention in prostate cancer. Mol Cancer Ther; 11(5); 1166–73. ©2012 AACR.This publication has 32 references indexed in Scilit:
- Epithelial cell polarity: a major gatekeeper against cancer?Cell Death & Differentiation, 2011
- Steps in prostate cancer progression that lead to bone metastasisInternational Journal of Cancer, 2011
- The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44Nature Medicine, 2011
- miRNAs in human cancerThe Journal of Pathology, 2010
- Matrix Metalloproteinase-Induced Epithelial-Mesenchymal Transition in Breast CancerJournal of Mammary Gland Biology and Neoplasia, 2010
- Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor modelNature Biotechnology, 2010
- The Roles of MicroRNAs in the Cancer Invasion-Metastasis CascadeCancer Microenvironment, 2010
- RETRACTED: A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer MetastasisCell, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- The functions of animal microRNAsNature, 2004